Free Republic

The internet is abuzz with tributes to a liquid chemical called methylene blue that is being sold as a health supplement. Over the past five or 10 years, methylene blue has come to be touted online as a so-called nootropic agent – a substance that enhances cognitive function. Vendors claim that it amps up brain energy, improves memory, boosts focus and dispels brain fog, among other supposed benefits. Health influencers, such as podcaster Joe Rogan, have sung its praises. In February 2025, shortly before he was confirmed as health and human services secretary, Robert F. Kennedy Jr. appeared in a...

In my first post in this series, I introduced the topic of chlorine dioxide as a therapeutic within its “political” context, not scientific. After a cursory introduction regarding its safety along with a few citations of its efficacy, I highlighted the regulatory, media, and judicial attacks against any who manufacture, recommend and/or sell chlorine dioxide for medicinal purposes via oral ingestion. A key point I brought attention to is the bizarre prohibition against “oral ingestion” that “they” are trying to block at all costs (despite studies of both oral and IV administration showing little to no toxicity and the fact...

Data from the phase III INTERACT3 study demonstrate that a new combination of treatments for stroke due to intracerebral hemorrhage (ICH) significantly improves the chances of surviving without major disability. The INTERACT3 study is the first-ever randomized controlled trial to show a clearly positive outcome for the treatment of ICH. Timely administration of the new treatment protocol—known as a Care Bundle—centered on the rapid control of high blood pressure, led to improved recovery, lower rates of death, and better overall quality of life. Professor Craig Anderson said, "Despite the high rates of ICH and its severity, there are few proven...

ScienceDaily (Aug. 18, 2008) — A new study conducted by researchers at Children's Hospital & Research Center Oakland shows that a century-old drug, methylene blue, may be able to slow or even cure Alzheimer's and Parkinson's disease. Used at a very low concentration – about the equivalent of a few raindrops in four Olympic-sized swimming pools of water – the drug slows cellular aging and enhances mitochondrial function, potentially allowing those with the diseases to live longer, healthier lives. A paper on the methylene blue study, conducted by Hani Atamna, PhD, and a his team at Children's, was published in...